Travere Therapeutics Inc.

Travere Therapeutics Inc.

World Rank (Aug-2026)
3245
Market Cap (Aug-2026)
5.857 Billion USD
World Rank (Jan-05-2024)
10,719
Market Cap (Jan-05-2024)
0.683 Billion USD
World Rank (Jul-30-2023)
7,507
Market Cap (Jul-30-2023)
1.287 Billion USD
World Rank (Jan-07-2022)
6,953
Market Cap (Jan-07-2022)
1.704 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TVTX
Employee Count
462
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
491 Million USD
Annual Operating Income in USD
-63 Million USD
Annual Net Income in USD
-26 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
605 Million USD
Total Liabilities in USD
490 Million USD
Total Equity in USD
115 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
TRAVERE THERAPEUTICS, INC.
Company Profile

Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.

Facts About Company

Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.

Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.

As on 2022, Travere Therapeutics has 462 employees.

Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share